c282y homozygosity
Recently Published Documents


TOTAL DOCUMENTS

25
(FIVE YEARS 1)

H-INDEX

9
(FIVE YEARS 0)

Genes ◽  
2021 ◽  
Vol 12 (8) ◽  
pp. 1162
Author(s):  
Miriam Sandnes ◽  
Marta Vorland ◽  
Rune J. Ulvik ◽  
Håkon Reikvam

HFE hemochromatosis is characterized by increased iron absorption and iron overload due to variants of the iron-regulating HFE gene. Overt disease is mainly associated with homozygosity for the C282Y variant, although the H63D variant in compound heterozygosity with C282Y (C282Y/H63D) contributes to disease manifestation. In this observational study, we describe the association between biochemical findings, age, gender and HFE genotype in patients referred from general practice to a tertiary care referral center for diagnostic workup based on suspected hemochromatosis due to persistent hyperferritinemia and HFE variants. C282Y and H63D homozygosity were, respectively, the most and least prevalent genotypes and we found a considerable variation in transferrin saturation and ferritin levels independent of HFE genotype, which may indeed represent a diagnostic challenge in general practice. While our results confirm C282Y homozygosity as the major cause of iron accumulation, non-C282Y homozygotes also displayed mild to moderate hyperferritinemia with median ferritin levels at 500-700 µg/L, well above the reference cut-off. Such findings have traditionally been ignored in the clinic, and initiation of iron depletion has largely been restricted to C282Y homozygotes. Nevertheless, superfluous iron can aggravate pathogenesis in combination with other diseases and risk factors, such as inflammation, cancer and hepatopathy, and this possibility should not be neglected by clinicians.


2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Patricia Martins Conde ◽  
Thomas Sauter ◽  
Thanh-Phuong Nguyen

AbstractHereditary haemochromatosis (HH) is an autosomal recessive disease, where HFE C282Y homozygosity accounts for 80–85% of clinical cases among the Caucasian population. HH is characterised by the accumulation of iron, which, if untreated, can lead to the development of liver cirrhosis and liver cancer. Since iron overload is preventable and treatable if diagnosed early, high-risk individuals can be identified through effective screening employing artificial intelligence-based approaches. However, such tools expose novel challenges associated with the handling and integration of large heterogeneous datasets. We have developed an efficient computational model to screen individuals for HH using the family study data of the Hemochromatosis and Iron Overload Screening (HEIRS) cohort. This dataset, consisting of 254 cases and 701 controls, contains variables extracted from questionnaires and laboratory blood tests. The final model was trained on an extreme gradient boosting classifier using the most relevant risk factors: HFE C282Y homozygosity, age, mean corpuscular volume, iron level, serum ferritin level, transferrin saturation, and unsaturated iron-binding capacity. Hyperparameter optimisation was carried out with multiple runs, resulting in 0.94 ± 0.02 area under the receiving operating characteristic curve (AUCROC) for tenfold stratified cross-validation, demonstrating its outperformance when compared to the iron overload screening (IRON) tool.


2020 ◽  
Vol 99 (10) ◽  
pp. 2295-2301
Author(s):  
Carl Eckerström ◽  
Sofia Frändberg ◽  
Lena Lyxe ◽  
Cecilia Pardi ◽  
Jan Konar

Abstract Early detection of individuals with hereditary hemochromatosis (HH) is important to manage iron levels and prevent future organ damage. Although theHFE mutations that cause most cases of HH have been identified, their geographic distribution is highly variable, and their contribution to iron overload is not fully understood. All new registered blood donors at the Sahlgrenska University hospital between 1998 and 2015 were included in the study. Donors with signs of iron overload at baseline and subsequent follow-up testing were recommended genotyping of the HFE gene. Of the 50,493 donors that were included in the study, 950 (1.9%) had signs of iron overload on both test occasions. Of the 840 donors with iron overload that performed HFE genotyping, 117 were homozygous for C282Y, and 97 were compound heterozygotes. The prevalence of C282Y homozygosity was 0.23%. Iron overload screening effectively detects individuals at risk of carrying the C282Y mutation of the HFE gene and enables early treatment to prevent HH complications.


Gut ◽  
2013 ◽  
Vol 62 (Suppl 1) ◽  
pp. A186.2-A187
Author(s):  
S Hazeldine ◽  
M Van Rijnsoever ◽  
P Bentley ◽  
J Olynyk

2012 ◽  
Vol 41 (6) ◽  
pp. 872-878 ◽  
Author(s):  
Yuanyuan Wang ◽  
Lyle C. Gurrin ◽  
Anita E. Wluka ◽  
Nadine A. Bertalli ◽  
Nicholas J. Osborne ◽  
...  

Hepatology ◽  
2012 ◽  
Vol 55 (6) ◽  
pp. 1722-1726 ◽  
Author(s):  
Paul C. Adams ◽  
Mark Speechley ◽  
James C. Barton ◽  
Christine E. McLaren ◽  
Gordon D. McLaren ◽  
...  

2012 ◽  
Vol 109 (6) ◽  
pp. 856-860 ◽  
Author(s):  
Yukitaka Shizukuda ◽  
Dorothy J. Tripodi ◽  
Gloria Zalos ◽  
Charles D. Bolan ◽  
Yu-Ying Yau ◽  
...  

2012 ◽  
Vol 5 ◽  
pp. CMAMD.S9935 ◽  
Author(s):  
James C. Barton ◽  
J. Clayborn Barton

Background Dupuytren's contracture (DC) and HFE hemochromatosis occur in some of the same at-risk populations and present with similar comorbid conditions. Methods We estimated DC prevalence in two cohorts of white Alabama hemochromatosis probands (294 C282Y homozygotes, 67 C282Y/H63D compound heterozygotes) in a retrospective study. We performed logistic regressions on DC using the following independent variables: age, body mass index, heavy ethanol consumption, serum ferritin, elevated serum AST/ALT, non-alcoholic fatty liver disease, viral hepatitis, cirrhosis, and diabetes. Results One man and two women with C282Y homozygosity had DC (prevalence 1.02%; 95% CI 0.35%–2.96%). A man with C282Y/H63D had DC (prevalence 1.49%; 95% CI 0.26%–7.98%). DC occurred as an autosomal dominant trait in his kinship. In regression analyses, no single variable predicted DC. We observed no new DC cases after the diagnosis of hemochromatosis (mean follow-up 12.9 ± 7.5 years (1 SD), and 9.0 ±5.1 years, respectively). Conclusions Our prevalence estimates of DC in white Alabama hemochromatosis probands are similar to those found in the white US population cohorts. DC risk was unrelated to the variables we studied.


Sign in / Sign up

Export Citation Format

Share Document